Islet cell transplantation for Type 1 diabetes

Journal of Diabetes

Volumn 2, Issue 1, 2010, Pages 16-22

  Matsumoto, Shinichi ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

Bioartificial islet; Islet transplantation; SUITO index; Type 1 diabetes

Indexed keywords

ANIMAL TISSUE; BIOARTIFICIAL ORGAN; CELL REGENERATION; EMBRYONIC STEM CELL; HUMAN; IMPLANT REGISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LIVING DONOR; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN DONOR; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETROVIRUS; REVIEW; XENOTRANSPLANTATION;

BIOARTIFICIAL ORGANS; BLOOD GLUCOSE; CADAVER; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVING DONORS; MULTICENTER STUDIES AS TOPIC; REGISTRIES; TISSUE DONORS; WAITING LISTS;

EID: 77953411099     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2009.00048.x     Document Type: Review

References (39)

1. DCCT Research Group. Diabetes Control and Complications Trial (DCCT). Update. Diabetes Care. 1990; 13: 427-33.
2. DCCT Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995; 18: 1415-27.
3. Matsumoto S, Noguchi H, Naziruddin B et al. Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent). 2007; 20: 357-62.
4. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343: 230-8.
5. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005; 54: 2060-9.
6. Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation. 2005; 79: 1304-7.
7. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006; 355: 1318-30.
8. Alejandro R, Barton F, Hering BJ, Wease S. 2008 update from the collaborative islet transplant registry. Transplantation. 2008; 86: 1783-8.
9. Matsumoto S, Tanaka K. Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs). J Hepatobiliary Pancreat Surg. 2005; 12: 227-30.
10. Matsumoto S, Okitsu T, Iwanaga Y et al. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation. 2006; 82: 460-5.
11. Noguchi H, Ueda M, Kobayashi N et al. Ductal injection of preservation solution increases islet yields in islet isolation and improves islet graft function. Cell Transplant. 2008; 17: 69-81.
12. Nagata H, Matsumoto S, Okitsu T et al. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation. 2006; 82: 327-31.
13. Noguchi H, Ueda M, Nakai Y et al. Modified twolayer preservation method (M-Kyoto ? PFC) improves islet yields in islet isolation. Am J Transplant. 2006; 6: 496-504.
14. Noguchi H, Ueda M, Hayashi S et al. Comparison of M-Kyoto solution and Histidine-tryptophan-ketoglutarate solution with a trypsin inhibitor for pancreas preservation in islet transplantation. Transplantation. 2007; 84: 655-8.
15. Matsumoto S, Rigley T, Qualley S, Kuroda Y, Reems J, Stevens RB. Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant. 2002; 11: 769-77.
16. Noguchi H, Iwanaga Y, Okitsu T, Nagata H, Yonekawa Y, Matsumoto S. Evaluation of islet transplantation from non-heart beating donors. Am J Transplant. 2006; 10: 2476-82.
17. Liu X, Matsumoto S, Okitsu T et al. Analysis of donor- and isolation-related variables from non-heart-beating donors (NHBDs) using the Kyoto islet isolation method. Cell Transplant. 2008; 17: 649-56.
18. Kenmochi T, Asano T, Maruyama M et al. Clinical islet transplantation in Japan. J Hepatobiliary Pancreat Surg. 2009; 16: 124-30.
19. Hering BJ, Kandaswamy R, Harmon JV et al. Transplantation of cultured islets from two-layer preserved pancreases in Type 1 diabetes with anti-CD3 antibody. Am J Transplant. 2004; 4: 390-401.
20. Hering BJ, Kandaswamy R, Ansite JD et al. Singledonor, marginal-dose islet transplantation in patients with Type 1 diabetes. JAMA. 2005; 293: 830-5.
21. Matsumoto S, Noguchi H, Naziruddin B et al. Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant. 2009. In press.
22. Markmann JK, Kaufman DB, Ricordi C, Schwab PM, Stock PG. Financial issues constraining the use of pancreata recovered for islet transplantation: a white paper. Am J Transplant. 2008; 8: 1588-92.
23. Ichii H, Ricordi C. Current status of islet transplantation. J Hepatobiliary Pancreat Surg. 2009; 16: 101-12.
24. Bellin MD, Kandaswamy R, Parkey J et al. Prolonged insulin independence after islet allotransplants in recipients with Type 1 diabetes. Am J Transplant. 2008; 8: 2463-70.
25. Matsumoto S, Yamada Y, Okitsu T et al. Simple evaluation of engraftment by secretory unit of islet transplant objects (SUITO) for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc. 2005; 37: 3435-7.
26. Yamada Y, Fukuda K, Fujimoto S et al. SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract. 2006; 74: 222-6.
27. Noguchi H, Yamada Y, Okitsu T et al. Secretory unit of islet in transplantation and engrafted islet rate indexes are useful for evaluating single islet transplantation. Cell Transplant. 2008; 17: 121-8.
28. Faradji RN, Tharavanij T, Messinger S et al. Longterm insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation. 2008; 86: 1658-65.
29. Senior PA, Zeman M, Paty BW, Ryan RA, Shapiro AM. Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant. 2007; 7: 91-8.
30. Aronovitz A, Josefson J, Fisher A et al. Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells. J Investig Med. 2008; 56: 985-96.
31. Matsumoto S, Okitsu T, Iwanaga Y et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet. 2005; 365: 1642-4.
32. Matsumoto S, Okitsu T, Iwanaga Y et al. Follow-up study of the first successful living donor islet transplantation. Transplantation. 2006; 82: 1629-33.
33. Barr ML, Belghiti J, Villamil FG et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006; 81: 1373-85.
34. Matsumoto S, Tanaka K, Strong DM, Reems JA. Effi-cacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation. 2004; 78: 839-43.
35. van der Laan LJ, Lockey C, Griffeth BC et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature. 2000; 407: 90-4.
36. Chen S, Ding JH, Bekeredjian R et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A. 2006; 103: 8469-74.
37. Chen S, Ding J, Yu C, Yang B, Wood DR, Grayburn PA. Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther. 2007; 14: 1102-10.
38. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72.
39. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009; 460: 49-52.